Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine

被引：10
|
作者：
Kelly, DL [1 ]
Kreyenbuhl, J [1 ]
Love, RC [1 ]
Van-Duong, Q [1 ]
Conley, RR [1 ]
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2003年 / 64卷 / 09期
关键词：
D O I：
10.4088/JCP.v64n0921f
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：1133 / 1134
页数：2
相关论文
共 50 条
  • [21] METABOLIC SYNDROME IN PATIENTS WITH SCHIZOPHRENIA RECEIVING LONG-TERM TREATMENT WITH LURASIDONE, QUETIAPINE XR, OR RISPERIDONE
    Newcomer, J.
    Tocco, M.
    Pikalov, A.
    Hsu, J.
    Cucchiaro, J.
    Loebel, A.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 119 - 120
  • [22] Metabolic syndrome in patients with schizophrenia receiving long-term treatment with lurasidone, quetiapine XR, or risperidone
    Newcomer, J.
    Tocco, M.
    Pikalov, A.
    Zheng, H.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2016, 33 : S105 - S105
  • [23] Metabolic Syndrome in Patients With Schizophrenia Receiving Long-Term Treatment With Lurasidone, Quetiapine XR, or Risperidone
    Newcomer, John W.
    Tocco, Michael
    Pikalov, Andrei
    Zheng, Hanzhe
    Cucchiaro, Josephine
    Loebel, Antony
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 199 - 199
  • [24] Review of six-month mortality in patients with low probability lung scans.
    Rajendran, JG
    Jacobson, AF
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 456 - 456
  • [25] Association of new-onset diabetes mellitus in adults with schizophrenia treated with clozapine versus patients treated with olanzapine, risperidone, or quetiapine: A systematic review and meta-analysis
    He, Qi
    Zhu, Peixin
    Liu, Xiyan
    Huo, Chunyue
    SCHIZOPHRENIA RESEARCH, 2024, 271 : 371 - 379
  • [26] Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: Results from a six-month prospective, multinational, observational study
    Treuer, Tamas
    Hoffmann, Vicki Poole
    Chen, Antony Kuang-Peng
    Irimia, Victoria
    Ocampo, Magdalena
    Wang, Gang
    Singh, Pritibha
    Holt, Susanna
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2009, 10 (04) : 729 - 740
  • [27] Metabolic syndrome in patients with schizophrenia receiving long-term treatment with lurasidone, extended release quetiapine, or risperidone
    Newcomer, J.
    Tocco, M.
    Pikalov, A.
    Zheng, H.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S564 - S564
  • [28] An observational study (IC-SOHO) comparing olanzapine, risperidone, quetiapine, and haloperidol in the treatment of patients with schizophrenia:: 12-month results
    Treuer, T
    Bartiene, R
    Blinc-Pesek, M
    Grigoriu, A
    Herman, E
    Molnár, B
    Pecenak, J
    Shakhnovich, T
    Szulc, A
    Leadbetter, J
    O'Mahoney, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S271 - S272
  • [29] Metabolic Benefits of Six-month Thiamine Supplementation in Patients With and Without Diabetes Mellitus Type 2
    Al-Attas, Omar
    Al-Daghri, Nasser
    Alokail, Majed
    Abd-Alrahman, Sherif
    Vinodson, Benjamin
    Sabico, Shaun
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2014, 7 : 1 - 6
  • [30] Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate - A six-month, open-label study
    Kremer, JM
    Habros, JS
    Kolba, KS
    Kaine, JL
    Borton, MA
    Mengle-Gaw, LJ
    Schwartz, BD
    Wisemandle, W
    Mekki, QA
    ARTHRITIS AND RHEUMATISM, 2003, 48 (10): : 2763 - 2768
12345